Homepage Fill Out Your Drug Screen Template
Jump Links

In the rigorous and detail-oriented domain of drug testing, a cornerstone document exists that encapsulates the entire process from collection to reporting, known as the Federal Drug Testing Custody and Control Form. Utilized predominately within situations requiring stringent oversight, this form serves as an essential tool in the documentation and validation of drug testing procedures. It meticulously records each phase of the testing process, beginning with the collector or the employer representative’s initial details about the employer and the Medical Review Officer (MRO), extending to specific identifiers like the employee's Social Security Number or Identification Number. Furthermore, it stipulates the testing authority which might range from the Department of Health and Human Services (HHS) to various Department of Transportation (DOT) agencies, while also specifying the reason for the test, which could range from pre-employment screening to post-accident investigation. The form also delineates the types of drugs being tested for, capturing the essence of thoroughness required in these sensitive matters. As the specimen progresses through its journey, the form documents the collection process, temperature checks, the method of the split or single specimen collection, observations, and remarks by the collector, thus ensuring the specimen's integrity is maintained until it reaches the laboratory. At the laboratory, the form tracks the specimen's reception, analysis, and the final results, be it negative, positive, or inconclusive, thereby endorsing the validity of the results through a documented chain of custody. Additionally, reconfirmation tests conducted by split testing laboratories, if necessary, are also recorded, underscoring the form’s comprehensive nature in maintaining authenticity and reliability in drug testing across federal domains.

Form Preview

FEDERAL DRUG TESTING CUSTODY AND CONTROL FORM

800-877-7484

SPECIMEN ID NO.

 

STEP 1: COMPLETED BY COLLECTOR OR EMPLOYER REPRESENTATIVE

LAB ACCESSION NO.

Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics Incorporated. © Quest Diagnostics Incorporated. All rights reserved. QD20315-FED. Revised 10/10. SC2K - 111192.

A. Employer Name, Address, I.D. No.

 

 

B. MRO Name, Address, Phone and Fax No.

 

 

 

 

 

 

 

 

 

C. Donor SSN or Employee I.D. No. _______________________________________________________________

 

 

 

 

D. SpecifyTesting Authority: HHS

NRC

DOT – Specify DOT Agency: FMCSA

FAA

FRA FTA PHMSA USCG

E. Reason forTest: Pre-employment

Random

Reasonable Suspicion Cause Post Accident

Return to Duty

Follow-up Other (specify) ____________________________

F. DrugTests to be Performed:

THC, COC, PCP, OPI, AMP

THC & COC Only

Other (specify) ________________________________________________

G. Collection Site Name:

 

 

 

 

 

Collection Site Code:

 

 

 

 

Address:

 

 

 

 

 

 

Collector Phone No.:

 

 

City, State and Zip:

 

 

 

 

 

Collector Fax No.:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

STEP 2: COMPLETED BY COLLECTOR (make remarks when appropriate) Collector reads specimen temperature within 4 minutes.

Temperature between 90° and 100° F? Yes No, Enter Remark

Collection: Split Single None Provided, Enter Remark

Observed, (Enter Remark)

REMARKS

STEP 3: Collector affixes bottle seal(s) to bottle(s). Collector dates seal(s). Donor initials seal(s). Donor completes STEP 5 on Copy 2 (MRO Copy)

STEP 4: CHAIN OF CUSTODY - INITIATED BY COLLECTOR AND COMPLETED BY TEST FACILITY

 

I certify that the specimen given to me by the donor identified in the certification section on Copy 2 of this form was

 

SPECIMEN BOTTLE(S) RELEASED TO:

 

collected, labeled, sealed, and released to the Delivery Service noted in accordance with applicable Federal requirements.

Quest Diagnostics Courier

 

 

X

 

 

 

 

 

FedEx

 

 

Signature of Collector

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AM

 

 

 

 

 

 

 

 

 

PM

 

 

 

 

 

(Print) Collector's Name (First, MI, Last)

Date (Mo./Day/Yr.)

 

Time of Collection

 

 

Name of Delivery Service

RECEIVED AT LAB OR IITF:

 

 

 

 

 

Primary Specimen

SPECIMEN BOTTLE(S) RELEASED TO:

 

X

 

 

 

 

 

Bottle Seal Intact

 

 

 

 

 

 

 

Yes No

 

 

 

Signature of Accessioner

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

If No, Enter remarks

 

 

 

 

 

 

 

 

 

in Step 5A.

 

 

 

(Print) Accessioner’s Name (First, MI, Last)

 

 

 

Date (Mo./Day/Yr.)

 

STEP 5A: PRIMARY SPECIMEN REPORT - COMPLETED BY TEST FACILITY

NEGATIVE

POSITIVE for:

Marijuana Metabolite ( 9-THCA)

6- Acetylmorphine

Methamphetamine

MDMA

DILUTE

 

 

Cocaine Metabolite (BZE)

Morphine

Amphetamine

MDA

 

 

 

PCP

Codeine

 

MDEA

REJECTED FOR TESTING

ADULTERATED

SUBSTITUTED

INVALID RESULT

 

 

REMARKS:

Test Facility (if different from above):

I certify that the specimen identified on this form was examined upon receipt, handled using chain of custody procedures, analyzed, and reported in accordance with applicable Federal requirements.

X

Signature of Certifying Scientist

(Print) Certifying Scientist's Name (First, MI, Last)

Date (Mo./Day/Yr.)

STEP 5b: COMPLETED BY SPLIT TESTING LABORATORY

RECONFIRMED FAILED TO RECONFIRM - REASON ____________________________________________

___________________________________________

I certify that the split specimen identified on this form was examined upon receipt, handled using chain of custody

procedures, analyzed and reported in accordance with applicable Federal requirements.

 

 

 

 

 

 

 

 

 

 

 

 

Laboratory Name

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

___________________________________________

X

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Signature of Certifying Scientist

 

 

 

(Print) Certifying Scientist's Name (First, MI, Last)

Date (Mo./Day/Yr.)

 

 

 

 

 

 

 

Laboratory Address

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OMB No. 0930-0158

PRESS HARD - YOU ARE MAKING MULTIPLE COPIES

File Attributes

Fact Name Fact Detail
Form Title Federal Drug Testing Custody and Control Form
Contact Number 800-877-7484
Form Number and Revision Date QD20315-FED, Revised 10/10
Trademark Statement Quest, Quest Diagnostics, the associated logo, and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics Incorporated.
Testing Authorities HHS, NRC, DOT (Includes FMCSA, FAA, FRA, FTA, PHMSA, USCG)
Possible Reasons for Test Pre-employment, Random, Reasonable Suspicion/Cause, Post Accident, Return to Duty, Follow-up, Other

How to Fill Out Drug Screen

After receiving the Federal Drug Testing Custody and Control Form, it's pivotal to fill it out with precision to ensure the testing process proceeds smoothly. This document connects the initial sample collection with the final test results, threading through the legal and procedural requirements essential for credibility. Following a methodical approach while completing this form will help avoid delays or disputes related to the drug screening process. Below are the detailed steps to guide you through this important task.

  1. Begin with Step 1, to be completed by the collector or an employer representative:
    • Enter the Employer's Name, Address, and Identification Number in section A.
    • Fill out the Medical Review Officer (MRO) Name, Address, Phone, and Fax No. in section B.
    • Record the Donor's Social Security Number (SSN) or Employee I.D. No. in section C.
    • In section D, specify the Testing Authority by checking the appropriate box and specify the DOT Agency if applicable.
    • Mark the Reason for Test in section E, and if 'Other', specify the reason.
    • Select Drug Tests to be Performed in section F, checking off the substances or specify if choosing 'Other'.
    • Input the Collection Site information including Name, Code, Address, and Phone/Fax No. in section G.
  2. Proceed to Step 2, which should be completed by the collector:
    • Verify if the specimen temperature is within the required range and mark 'Yes' or 'No', adding remarks if needed.
    • Indicate the collection type and make any pertinent remarks.
  3. In Step 3, the collector affixes the bottle seal(s), dates it, and has the donor initial it. The donor then completes STEP 5 on Copy 2 (MRO Copy).
  4. Under Step 4, Chain of Custody, the collector certifies that the specimen was handled according to the federal requirements and documents the release to the delivery service.
    • Include the signature and printed name of the collector, the date, and time of collection, and name of the delivery service.
  5. The subsequent sections, Step 5A and Step 5b, are for the testing facility and, if applicable, the split testing laboratory. They provide the results and handle the chain of custody confirmation.
    • These sections are typically filled out by laboratory personnel, documenting the test results and any additional remarks.

Once you've accurately completed all relevant sections of the Federal Drug Testing Custody and Control Form, ensure all parties have initialed and dated as required to maintain the integrity of the process. Congratulations on taking a significant step towards completing the drug testing procedure with due diligence and attention to detail.

Frequently Asked Questions

What is the Federal Drug Testing Custody and Control Form?

The Federal Drug Testing Custody and Control Form is a standardized document used by employers and drug testing facilities to record and track the process of collecting, handling, and testing specimens for drugs. It ensures that the specimen is accurately linked to the correct individual and that the testing process adheres to applicable federal regulations, thereby maintaining the integrity and confidentiality of the testing process.

Who completes the Federal Drug Testing Custody and Control Form?

The form is completed by multiple parties throughout the drug testing process:

  1. Collector or Employer Representative: Initiates the form at the time of specimen collection.
  2. Collector: Fills out the details regarding specimen collection, handling, and transfer.
  3. Test Facility Personnel: Document the receipt of the specimen and the test results.
  4. Donor: Provides necessary identification information and acknowledges the collection and sealing of the specimen.

Which agencies' regulations can dictate the use of this form?

The form is used under the authority of different federal agencies depending on the specific requirements of the industry or sector. These include the Department of Health and Human Services (HHS), the Nuclear Regulatory Commission (NRC), and the Department of Transportation (DOT), among others. The DOT itself has various agencies like the Federal Motor Carrier Safety Administration (FMCSA) and the Federal Aviation Administration (FAA) which utilize this form tailored to their specific testing requirements.

What reasons for testing are indicated on the form?

The form outlines several reasons for conducting a drug test, including:

  • Pre-employment
  • Random
  • Reasonable Suspicion/Cause
  • Post-Accident
  • Return to Duty
  • Follow-up
  • Other reasons that can be specified as needed

What types of drug tests are typically performed?

The form provides options for a variety of substances for which testing can be performed, including but not limited to THC (marijuana), COC (cocaine), PCP (phencyclidine), OPI (opioids), and AMP (amphetamines). Employers can specify other drugs to be tested based on their specific requirements or federal regulations guiding their industry.

How is the specimen collection process documented?

The collection process is carefully documented in the form through several steps to ensure accuracy and integrity. This includes checking the temperature of the specimen within 4 minutes of collection to ensure its validity, indicating whether the collection was observed, and noting whether the collection was split or single. Remarks can be entered if there are deviations from the expected process.

What happens if a specimen bottle seal is broken or tampered with?

If a specimen bottle seal is found to be broken or tampered with upon receipt at the test facility, the form provides space for accessioner remarks. This could lead to the specimen being rejected for testing. The integrity of the seal is crucial for ensuring that the specimen has not been contaminated or altered.

What does a positive result indicate on the form?

A positive result on the form indicates that the specimen tested positive for one or more of the substances listed under the test section. The form also allows for the documentation of dilute, adulterated, substituted, or invalid test results, each of which has specific implications and may require further action according to federal guidelines and employer policies.

Common mistakes

One common mistake individuals make when filling out the Drug Screen form is failing to provide accurate and complete information in section A, which asks for the Employer Name, Address, and I.D. No. This information is crucial for ensuring the test results are correctly attributed and reported to the proper employer.

Another error occurs in section C, where individuals are required to enter their Social Security Number (SSN) or Employee I.D. No. Incorrectly entering this number can lead to misidentification and may result in the wrong individual receiving or being associated with the drug test results.

Incorrectly specifying the testing authority in section D is also a frequent mistake. The form provides options such as HHS, NRC, DOT, and specifies various DOT agencies. Choosing the wrong authority or agency can affect the compliance and applicability of the test, especially since different organizations may have unique testing standards and requirements.

In section E, which requires the reason for the test, some people mistakenly check the wrong box or fail to specify an "Other" reason when necessary. This can lead to confusion about the purpose of the test, which can be critical in situations such as post-accident testing or follow-up tests for returning employees.

When it comes to section F, listing the drugs to be tested, a mistake often made is not specifying all relevant substances or selecting the wrong ones. This part is essential for ensuring the laboratory screens for the correct substances, impacting the relevance and effectiveness of the entire screening process.

Lastly, a crucial mistake involves the handling of section G, related to the Collection Site information. Incorrect or incomplete details about the collection site can jeopardize the integrity of the sample and the testing process, leading to delays or the potential for the sample to be challenged on procedural grounds.

Documents used along the form

When conducting drug screening, especially in contexts requiring strict adherence to regulations such as workplace policies or legal requirements, a Drug Screen form is a crucial document. However, it is often one part of a larger array of forms and documents necessary to ensure the process is carried out properly, comprehensively, and fairly. Below is a list of other forms and documents frequently used alongside the Drug Screen form, each serving its unique purpose in the drug testing process.

  • Consent Form: This is a document that must be signed by the employee or individual being tested, giving their explicit permission for the drug test to be conducted and for the results to be released to the specified parties.
  • Chain of Custody Form: Aside from the section included in the Drug Screen form, a more detailed Chain of Custody document is often used to record each person who handles the specimen, ensuring its integrity from collection to laboratory analysis.
  • Medical Review Officer (MRO) Report: This report provides the analysis and final determination of the drug test by a qualified MRO. It outlines whether the results are negative or positive and any medical explanations for certain results.
  • Substance Abuse Professional (SAP) Evaluation Report: Required particularly in DOT-regulated industries, this document is completed by a SAP and outlines recommended treatment and follow-up testing for individuals who have violated drug and alcohol program regulations.
  • Return-to-Duty Agreement: For individuals returning to work after a violation of drug and alcohol policies, this document outlines the conditions under which they are being allowed to return, including any ongoing testing requirements.
  • Follow-Up Testing Schedule: This is a schedule that outlines the frequency and duration of drug tests that an individual must undergo after returning to duty, as part of a follow-up to a positive test or treatment program.
  • Employee Assistance Program (EAP) Referral: If an employee's drug test is positive, they might be referred to an EAP for counseling, treatment, and rehabilitation services. This document formalizes that referral.
  • Drug-Free Workplace Policy Acknowledgment: This form is signed by employees to acknowledge that they understand the employer's drug-free workplace policy and the consequences of violating it.
  • Test Results Release Form: Signed by the individual being tested, this form authorizes the release of drug test results to authorized parties, such as an employer or legal representative.

Together, these documents ensure that the drug testing process is not only thorough but also safeguards the rights and privacy of the individuals being tested. Employers and organizations are advised to maintain accurate records of all documents to demonstrate compliance with relevant laws and policies. Handling these documents with confidentiality and care is paramount to uphold trust and integrity throughout the process.

Similar forms

The Medical History Form, much like the Drug Screen Form, gathers crucial personal data but focuses on a broader spectrum of health-related information. Both forms collect identification details, such as the individual's name, Social Security Number (SSN), or Employee Identification Number (EIN), to ensure the correct association of the health records with the individual in question. The Medical History Form, however, delves deeper into past medical conditions, surgeries, allergies, and medication history, providing a comprehensive overview of the patient's health background. This depth of information assists healthcare providers in making informed decisions, similar to how the Drug Screen Form's detailed findings help employers or regulatory authorities ensure workplace safety and compliance.

Employment Application Forms share commonalities with Drug Screen Forms in their role in the pre-employment process. They both require personal information for identification purposes—such as name, address, and sometimes the SSN to uniquely identify the applicant. Though the Employment Application Form primarily collects data on the candidate's qualifications, employment history, and references, both it and the Drug Screen Form serve as critical steps in the hiring process. Specifically, the Drug Screen Form is integral in sectors where maintaining a drug-free environment is mandatory, reflecting the applicant's eligibility for the role based on lifestyle choices.

Consent Forms for Medical Procedures similarly capture patient identifiers and detailed information about the specific medical service to be provided, analogous to how the Drug Screen Form specifies the type of drug tests to be conducted (e.g., for THC, COC, PCP). Both forms require clear acknowledgment from the participant—either the patient or the individual being tested—confirming their understanding and agreement to the process. This informed consent is crucial, ensuring transparency and compliance with legal and ethical standards, whether it be for a medical procedure or a drug screening protocol.

The Laboratory Test Order Form is another document that bears resemblance to the Drug Screen Form, particularly in the context of how specimens are handled, documented, and analyzed. Both documents detail the type of tests to be performed, include unique identification numbers for tracking, and outline specific instructions for the collection and handling of specimens to ensure integrity. The Laboratory Test Order Form is used across various medical disciplines for diverse testing purposes, serving a similar function in the careful coordination between collection sites, laboratories, and ordering physicians or entities.

The Chain of Custody Form, used in legal and medical contexts, parallels the Drug Screen Form in its meticulous tracking of the specimen from collection to analysis. It documents each individual who handles the specimen, the transfer of possession, and the condition of the specimen at each stage. This continuous documentation ensures the specimen's integrity, making it admissible in court or valid for medical interpretation. The Drug Screen Form incorporates chain of custody elements within its structure, emphasizing the form’s dual role in maintaining procedural integrity and providing legally defensible results.

Dos and Don'ts

When filling out the Federal Drug Testing Custody and Control Form, accuracy and attention to detail are crucial. The process can seem daunting, but following a set of dos and don'ts will help ensure the form is completed correctly, reducing the risk of delays or issues with the testing process.

Things You Should Do

  1. Review all sections carefully before starting to ensure you understand which parts are to be completed by you.
  2. Provide accurate information for the employer and donor sections, including full names, addresses, and identification numbers, to ensure there is no confusion regarding the test subjects and results.
  3. Specify the type of test and authority clearly, choosing from the options such as DOT, FMCSA, FAA, FRA, etc., and state the reason for the test (e.g., pre-employment, random, reasonable suspicion/cause).
  4. Ensure the collection site information is correct and includes the site name, address, and contact information of the collector.
  5. Ensure the donor's initials are placed next to the bottle seal(s) as required in Step 3 to affirm that the specimen is correctly labeled and sealed.

Things You Shouldn't Do

  1. Avoid leaving blanks in required fields. If a section does not apply, fill it with "N/A" or "None," as per the form's instructions, to indicate that the field was not overlooked.
  2. Don't rush through the process without verifying the temperature of the specimen and the integrity of the bottle seal, as these are critical for the validity of the sample.
  3. Do not forget to get the necessary initials and signatures at every step of the form to maintain the chain of custody, which is vital for the test's legitimacy.
  4. Avoid using incorrect or outdated forms. Ensure you are using the most current version of the form, as indicated by the revision date, to comply with the latest federal requirements.
  5. Do not handle the form carelessly after completion. Ensure it is delivered to the appropriate parties without damage or alterations to maintain its integrity.

Correctly filling out the Federal Drug Testing Custody and Control Form is essential for the drug testing process. By following these guidelines, individuals and employers can contribute to a smooth and efficient procedure, ensuring that the results are accurate and reliable.

Misconceptions

Understanding the Federal Drug Testing Custody and Control Form is crucial for both employers and employees. However, several misconceptions can lead to confusion. Let's clear up some common misunderstandings:

  • Only illegal drugs are tested. This form lists various substances, including prescription drugs, that are tested for. The purpose is to ensure safety and compliance with regulations, not just to check for illegal drug use.

  • Any mistake on the form invalidates the test. While accuracy is critical, minor errors can often be corrected without invalidating the entire test. It's the integrity of the specimen and the collection process that are most crucial.

  • The collection process is the same for all tests. The form specifies different testing authorities and reasons for testing. Procedures can vary depending on the regulatory requirements of agencies like the DOT, FAA, or FMCSA.

  • Employers can decide not to test for certain substances. The form does provide options for the employer to specify which drug tests to perform. However, these choices are bound by federal and state regulations and the specific policies of the regulatory authority involved.

  • A positive result immediately leads to termination. Positive results undergo further validation and must be reviewed by a Medical Review Officer (MRO) before any action is taken. Employers also consider their own policies and the specifics of the situation.

  • The collection site has no liability. Collection sites play a crucial role in maintaining the integrity of the sample and the testing process. Errors or negligence at this stage can compromise the test results and have legal implications.

  • Results are shared with all parties immediately. Results go through a chain of custody and confidentiality protocols. They are primarily shared with the MRO and the employer, in compliance with privacy laws and regulations.

Correctly understanding the roles, responsibilities, and procedures outlined in the Federal Drug Testing Custody and Control Form ensures the integrity of the drug testing process, protects individual rights, and upholds safety standards.

Key takeaways

Understanding the intricacies of the Federal Drug Testing Custody and Control Form (CCF) is essential for ensuring the integrity and legality of drug screening processes. This form plays a pivotal role in documenting the collection and handling of drug test specimens, which is critical for employment and compliance in various industries. Here are five key takeaways about filling out and using this form effectively.

  • Accuracy is paramount when completing the form. It begins with the employer or employer representative, who must meticulously fill in details such as the employer’s name, address, ID number, and the Medical Review Officer (MRO) details. Ensuring these details are correct is crucial to the test's validity and subsequent actions based on its results.
  • The type of test and reason for testing must be clearly specified. The form allows for the selection of specific testing authority (e.g., DOT, NRC, HHS) and the reason for the test (e.g., Pre-employment, Random, Reasonable Suspicion/Cause). Each choice directs the process and interpretation of the test, impacting decisions on employment and compliance.
  • Chain of custody is a critical aspect of the drug testing process, which is thoroughly documented across the form’s steps. From collection to the laboratories, every handoff is recorded, including temperatures of the specimen and the integrity of its seal. This unbroken chain is vital for defending the test results' validity in any dispute.
  • The collector’s role is foundational to the process, involving the proper identification of the donor, correct specimen collection, and ensuring the specimen is within the correct temperature range. Missteps in collection can compromise the specimen, leading to potential retests or questions about the results’ integrity.
  • Finally, the testing facility's responsibilities are clearly delineated, including verifying the specimen's seal integrity upon receipt, conducting the specified tests, and reporting the results accurately. If the initial test is positive, a confirmation test must be done. The results, whether negative or positive for controlled substances, have significant implications for the donor and require precise documentation.

In conclusion, the Federal Drug Testing Custody and Control Form is a critical document that serves as the backbone of the drug testing process, ensuring fairness, legality, and accuracy every step of the way. Both the employers and the testing facilities must handle the form with the utmost care to maintain the integrity of the drug testing process.

Please rate Fill Out Your Drug Screen Template Form
5
Exemplary
4 Votes